Ceribell is a venture-backed medical device start-up company founded in 2014 by two
faculty members at Stanford University, who were frustrated at the conventional EEG
systems. To meet the clinical unmet needs, we have developed a rapid response EEG
system, which makes the diagnosis of neurological patients drastically more efficient.